The first Biogen trade was made in Q1 2013.
Since then Jeremy Grantham bought shares seventeen more times and sold shares on 25 occasions. The investor completely sold their stake between Q2 2023 and Q4 2023.
Avg closing price
Price range
Sold -56.7 Thousand shares
Q4 2023
Avg closing price
$245.62
Price range
$222.59
-
$267.94
Sold 42.9% shares (-42.7 Thousand shares)
Q3 2023
Avg closing price
$267.47
Price range
$253.30
-
$285.89
Sold 29.2% shares (-41.1 Thousand shares)
Q2 2023
Avg closing price
$297.68
Price range
$275.25
-
$318.06
Increased shares by 4.0% (+5.4 Thousand shares)
Q1 2023
Avg closing price
$276.70
Price range
$256.56
-
$292.34
Sold 4.0% shares (-5.7 Thousand shares)
Q4 2022
Avg closing price
$282.44
Price range
$253.67
-
$306.72
Sold 0.3% shares (-400 shares)
Q3 2022
Avg closing price
$212.38
Price range
$194.69
-
$276.61
Increased shares by 10.7% (+13.7 Thousand shares)
Q2 2022
Avg closing price
$204.43
Price range
$187.54
-
$223.02
Increased shares by 28.7% (+28.4 Thousand shares)
Q1 2022
Avg closing price
$217.46
Price range
$193.77
-
$244.14
Increased shares by 6.1% (+5.7 Thousand shares)
Q4 2021
Avg closing price
$257.12
Price range
$223.92
-
$287.77
Increased shares by 18.2% (+14.4 Thousand shares)
Q3 2021
Avg closing price
$327.75
Price range
$282.99
-
$369.05
Increased shares by 8.8% (+6.4 Thousand shares)
Q2 2021
Avg closing price
$302.94
Price range
$259.00
-
$414.71
Increased shares by 23.7% (+13.9 Thousand shares)
Q1 2021
Avg closing price
$269.69
Price range
$242.95
-
$284.63
Increased shares by 268.2% (+42.7 Thousand shares)
Q4 2020
Avg closing price
$257.97
Price range
$236.26
-
$355.63
Sold 20.5% shares (-4.1 Thousand shares)
Q2 2020
Avg closing price
$300.59
Price range
$258.66
-
$342.55
Sold 33.1% shares (-9.91 Thousand shares)
Q1 2020
Avg closing price
$303.47
Price range
$268.85
-
$341.04
Sold 23.2% shares (-9.07 Thousand shares)
Q4 2019
Avg closing price
$277.46
Price range
$220.06
-
$304.07
Sold 3.7% shares (-1.49 Thousand shares)
Q3 2019
Avg closing price
$232.85
Price range
$217.44
-
$243.88
Increased shares by 43.1% (+12.2 Thousand shares)
Q2 2019
Avg closing price
$230.90
Price range
$219.29
-
$241.72
Increased shares by 387.9% (+22.5 Thousand shares)
Q1 2019